Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,696 | -30,287 | -32,108 | -20,173 | -66,160 |
| Depreciation Amortization | 4,634 | 3,393 | 2,299 | 1,128 | 5,014 |
| Accounts receivable | -1,738 | -758 | -544 | -1,881 | -660 |
| Accounts payable and accrued liabilities | -716 | 364 | 203 | 983 | 3,891 |
| Other Working Capital | -31,394 | -27,072 | -8,149 | -8,052 | -772 |
| Other Operating Activity | 13,021 | 7,185 | 6,894 | 4,084 | 7,219 |
| Operating Cash Flow | $-47,889 | $-47,175 | $-31,405 | $-23,911 | $-51,468 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,079 | 33,155 | 18,135 | 16,016 | 21,173 |
| PPE Investments | -2,973 | -2,119 | -1,666 | -717 | -1,609 |
| Other Investing Activity | -4,500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $8,606 | $31,036 | $16,469 | $15,299 | $19,564 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 36,463 | 6,898 | 4,417 | 2,434 | 41,991 |
| Financing Cash Flow | $36,463 | $6,898 | $4,417 | $2,434 | $41,991 |
| Beginning Cash Position | 36,449 | 36,449 | 36,449 | 36,449 | 26,362 |
| End Cash Position | 33,629 | 27,208 | 25,930 | 30,271 | 36,449 |
| Net Cash Flow | $-2,820 | $-9,241 | $-10,519 | $-6,178 | $10,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,889 | -47,175 | -31,405 | -23,911 | -51,468 |
| Capital Expenditure | -3,009 | -2,131 | -1,672 | -717 | -1,609 |
| Free Cash Flow | -50,898 | -49,306 | -33,077 | -24,628 | -53,077 |